Kin1 and Kin2 are S. cerevisiae counterparts of Par-1, the C. elegans kinase essential for the establishment of polarity in the one cell embryo. Here, we present evidence for a novel link between Kin1, Kin2 and the secretory machinery of the budding yeast. We isolated KIN1 and KIN2 as suppressors of a mutant form of Rho3, a Rho-GTPase acting in polarized trafficking. Genetic analysis suggests that KIN1 and KIN2 act downstream of the Rab-GTPase Sec4, its exchange factor Sec2, and several components of the vesicle tethering complex, the Exocyst. We show that Kin1 and Kin2 physically interact with the t-SNARE Sec9 and the Lgl homologue Sro7, proteins acting at the final stage of exocytosis. Structural analysis of Kin2 reveals that its catalytic activity is essential for its function in the secretory pathway, and implicates the conserved 42 amino acid tail at the carboxyterminal of the kinase in auto-inhibition. Finally, we find that Kin1 and Kin2 induce phosphorylation of t-SNARE Sec9 in vivo and stimulate its release from the plasma membrane. In summary, we report the finding that yeast Par-1 counterparts are associated with and regulate the function of the exocytic apparatus via phosphorylation of Sec9.
INTRODUCTION
Par-1 has been implicated in providing intracellular polarization cues in various biological systems. Initially, Par-1 has been described in C. elegans as one of the "partitioning" genes essential for anterior-posterior axis specification and asymmetry of zygote division (Kemphues et al., 1988) . Homologous genes have been characterized in S. pombe (kin1+) (Levin and Bishop, 1990) , Drosophila melanogaster (dPAR-1) (Tomancak et al., 2000) and mammalian cells (mPARs: p78, EMK, MARK) (Drewes et al., 1995; Bohm et al., 1997) . The mechanism of cell polarity regulation by Par-1 appears to differ depending on the organism and the cellular context. Some reports link Par-1 function to restricting localization of polarity determinants: P granules and PIE-1 in C. elegans (Kemphues et al., 1988; Tenenhaus et al., 1998) , Oscar, Orb, BicD and Egl in Drosophila oocyte (Tomancak et al., 2000; Huynh et al., 2001; Vaccari and Ephrussi, 2002) and Par-3 via 14-3-3 in Drosophila follicular epithelium . Others find that Par-1 regulates stability, density and/or organization of the microtubule cytoskeleton as in Drosophila and mammalian cells (Drewes et al., 1997; Shulman et al., 2000; Cox et al., 2001; Huynh et al., 2001; Doerflinger et al., 2003; Cohen et al., 2004) .
In the budding yeast Saccharomyces cerevisiae the Par-1 counterparts, Kin1 and Kin2, have been isolated by homology to the kinase family of viral oncogenes (Levin et al., 1987) . They belong to the Snf1 kinase family of the CaMK (Ca2+/ calmodulindependent kinase II) group (Hanks et al., 1988) . Kin1 and Kin2 are structurally similar serine/threonine kinases with a N-terminally located catalytic domain and C-terminal regulatory domain (Lamb et al., 1991; Donovan et al., 1994) . The catalytic core and the C-terminal 42 amino acid tail are highly conserved between S. pombe, S. cerevisiae, C. elegans, D. melanogaster and mammalian orthologs of Par-1. Therefore, S. cerevisiae, as a polarized organism highly amenable to genetic analysis, represents an advantageous model to study yeast Par-1 orthologs. However, little is known about the function of Kin1 and Kin2 in S. cerevisiae. This work investigates the role of Kin1 and Kin2 proteins in polarized exocytosis in yeast. In S. cerevisiae polarity is manifested by asymmetric growth of the bud, which requires polarized transport of Golgi-derived vesicles and their subsequent docking and fusion with the plasma membrane at the bud tip. Golgi-to-plasma membrane transport is dependent on the actin cytoskeleton and Rho/Rab GTPases, such as: Rho3, Cdc42 and Sec4. Definition of the docking site and vesicle tethering is mediated by a multi-protein Exocyst complex, comprised of eight subunits: Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70 and Exo84 . Following docking, vesicle fusion with the plasma membrane involves correct pairing of one vesicle SNARE, Snc1/2, with two membrane tSNAREs: Sso1/2 and Sec9 (Aalto et al., 1993; Protopopov et al., 1993; Brennwald et al., 1994) . While the aforementioned molecules constitute the core of the secretory machinery, polarized exocytosis is fine-tuned by many additional components.
Here, we report that yeast Par-1 orthologs regulate exocytosis. We show that Kin1 and Kin2 genetically interact with multiple components of the late exocytic machinery and physically associate with the t-SNARE Sec9 and the SNARE-binding protein Sro7. We demonstrate that Kin1 and Kin2 induce phosphorylation of Sec9 and its release from were utilized to subclone HSL1 (1-462), GIN4 (1-432), KCC4 (1-437), YPL141C (1-387) and YPL150W (1-426) into pRS426 vector. Not1/Sal1 sites were used to subclone SNF1 (1-432) and KIN4 (1-366) into the pRS426 vector. Galactose-inducible KIN1 and KIN2 constructs were generated by insertion of PCR-amplified fragments behind the GAL promoter of GAL/HIS/CEN (BamH1/Sal1 sites used) and GAL/LEU/CEN (BamH1/Xho1 sites used) vectors, respectively. Generation of high copy SEC9 construct and Sec9-CT (402-651) GST-fusion protein were described elsewhere . Sec9-NT1 (1-168) and Sec9-NT2 (166-401) GST-fusion proteins were obtained by subcloning Sec9-NT1 and Sec9-NT2 into the BamH1/Sal1 and BamH1/EcoR1 sites, respectively, of the pGEX4T1 vector (Pharmacia Biotech. Inc.). The Sec9-NT2-S315A mutant was created by fusion PCR via mutation-incorporating primers. All mutants were verified by sequencing. Generation of GST-KIN2 kinase domain(1-520) construct was obtained by subcloning a PCR generated fragment containing kin2-NT(1-520) into the BamHI-Xho1 sites of the pGEX4T1 vector. The C-terminal Kin2 fragments kin2- CT(523-1147) and kin2-CT∆42(523-1106) were placed under the control of a T7 promoter for transcription and translation by PCR amplification. The upstream oligo was designed for translation beginning at residue 532 in the KIN2 coding sequence. The downstream oligo was designed to anneal approximately 40 base pairs distal to the stop codon of KIN2. PCR products for coupled translation/transcription were generated using templates containing either KIN2 or KIN2-∆42 mutant. Translation of each PCR product resulted in a radiolabeled protein of the expected size on SDS-PAGE.
Suppression Assays
Late sec mutant cells were transformed with high copy plasmids (vector, KIN1, KIN2, etc) or a galactose-inducible Kin2 construct (vector, GALKIN2 )and grown on selective medium, picked into microtiter plates and replica plated onto YP-D medium (YP supplemented with 2% glucose) or YP-Gal (YP supplemmented with 1% galactose). Transformants were tested for growth at permissive (25°C) and restrictive (14°, 33°, 35°, 37°C) temperatures.
Two-Hybrid Analysis
ORFs of kin2-CT (521-1147) and kin2-CT∆42 (521-1106) were subcloned as N-terminal fusion fragments into Nco1/BamH1 sites of pAS1-CYH2 GAL4-binding domain vector (BD). ORFs of KIN2 (1-1147), KIN2-NT (1-526), kin2-CT (521-1147), KIN2-FL∆42 (1-1106), kin2-CT∆42 (521-1147) were inserted as N-terminal fusion fragments into Nco1/BamH1 sites of pACT2 GAL4-activation domain vector (AD). Constructs were transformed into the PJ694α strain containing GAL4-inducible HIS3 and ADE reporter genes. Construct expression was verified by Western blotting. Transformants expressing interacting proteins gained the ability to grow on -His and -Ade media. As a control empty BD and AD vectors were analyzed for the interaction with each AD and BD fusion construct, respectively. Only signals detected in the absence of control background were considered positive.
In Vitro Binding Assays PCR generated fragments containing kin2- CT(523-1147) and kin2-CT∆42(523-1106) were placed under control of a T7 promoter and in vitro transcribed and translated using a coupled reticulocyte lysate transcription/translation system(TnT; Promega) in the presence of 35 S methionine. The radiolabelled proteins were diluted in binding buffer (10mM Hepes KOH pH 7.4. 140mM KCl, 2mM MgCl2 and 0.5% Triton) with GSTKin2 kinase domain (present at about 1 µM) for 1 hour at 4°C. Supernatant and pellet fractions were separated and run on a 7% gel,dried and exposed to film. Binding of radiolabelled proteins was quantified using the Phosphoimager screen and STORM ImageQuant software (Molecular Dynamics).
Construction of Deletion Strains
Gene disruption was performed via homologous recombination. Initially, flanking sequences upstream and downstream of the target ORF were introduced into the integration vector respectively upstream and downstream of the coding sequence of the appropriate selection marker. Plasmids were linearized prior to the transformation. The KIN1 gene was disrupted by the insertion of the LEU2 marker via pRS305 LEU2 vector. KIN2 gene was disrupted by the insertion of the HIS3 marker via pRS303 HIS3 vector. The genotype of the yeast strain transformed with these constructs was MAT a/α; 112;  his3-∆200/his3-∆200. Diploids were selected on either -His or -Leu medium and sporulated. Tetrads were dissected and analyzed for the presence of the selective markers and the viability at different temperatures. Disruption was confirmed by PCR and immunoblotting with α−Kin1 and α-Kin2 antibodies. Crossing of the single kin1∆ and kin2∆ deletion strains generated a strain with the double deletion kin1∆, kin2∆, which was analyzed in a similar fashion. The SNF1 gene was disrupted using a purified PCR product containing SNF1 sequences flanking the Kanamycin gene (snf1∆::Kan R ), which was transformed into the wild-type strain and in the strain homozygous for the KIN1 deletion and heterozygous for the KIN2 deletion: MAT a/a; kin1∆::LEU2/kin1∆::LEU2; KIN2/kin2∆::HIS3; 112; to create the triple deletion mutant kin1∆, kin2∆, snf1∆. YPD-G418 plates were used for the selection of the Kan R -containing transformants. Diploids were sporulated, and tetrads were analyzed for marker distribution. Generation of the triple mutant kin1∆, kin2∆, snf1∆ was confirmed by PCR.
Subcellular Fractionation
Procedure was described elsewhere in detail (Lehman et al., 1999) . Three strains were used: vector only (pRS426), KIN1 on high copy vector and KIN2 on high copy vector. Cells were washed, spheroplasted, lysed and divided into two pools, which were subjected to the differential treatment with or without Triton X-100 and centrifuged at 30,000xg. Supernatant and pellet fractions were isolated and normalized for further analysis. Samples boiled in SDS sample buffer were subjected to 7% SDS-PAGE and blotted with affinity purified antibodies to Kin1, Kin2 and Sso1/2. Signal was quantified using the Phosphoimager screen and STORM ImageQuant software (Molecular Dynamics).
Bgl2 Secretion Assays
Secretion assays examining the effect of multicopy KIN2 were perfomed on sec15-1 mutant cells (ura3-52; sec15-1) transformed with KIN2 on a high copy vector or vector only (pRS426). Cells were grown overnight at 25°C and then shifted to 36°C for 1 hour.
Cells were then processed for Bgl2 secretion as described previously . Secretion assays on GAL induced KIN1 were performed on sec1-1 mutant cells (GAL+, 112 ; containing vector only (GAL/LEU2) or galactose inducible KIN1 on GAL/LEU2integrative vector as well as a wild type control strain. Cells were grown overnight to an OD 599 =0.5 in YP-raffinose (3%) medium at 25°C and then induced with 1% galactose for 2 hours before shifting the cells to 33°C for 2 hours. Cells were then processed for Bgl2 secretion as described previously .
Native Immunoprecipitation
Cells from strains containing either high copy KIN1, KIN2 or vector alone were grown O/N in SC-D medium to OD 599 =0.5, then shifted for 2 hours to grow in YP-D medium at 25°C to OD 599 =1 to the total of 266 OD units. Subsequently, cells were harvested, washed in ice-cold 10:20:20 buffer (10 mM Tris, 20 mM sodium azide, 20 mM sodium fluoride) and spheroplasted in 17.8 ml of spheroplast buffer (100 mM Tris, 20 mM sodium azide, 20 mM sodium fluoride, 1.2 M sorbitol, 21 mM β-mercaptoethanol, and 0.1 mg/ml of 100T Zymolyase) for 30 min at 37°C. Spheroplasts were lysed in 8.8 ml of ice-cold lysis buffer (20 mM Hepes-KOH, 150 mM KCl, 0.5% IGEPAL) with protease inhibitors (PIC): 2 mM 4-(2-aminoethyl)benzenesulfonyl fluoride, 1 mM PMSF, 20 µM Pepstatin A, 2 µg/ml leupeptin, aprotinin, antipain. The insoluble material was pelleted by 10 min spin in a 4°C microfuge and the supernatant was used to set up IP reactions (1ml/1 IP). Saturating amounts of affinity purified antibodies to Kin1 and Kin2 were incubated with the lysate for 1.5 h on ice. In parallel, control IPs were set up with equal amounts of purified preimmune IgG. Next, ProteinA-Sepharose was added to the lysates (60 µl of 1:1 suspension per IP) and tubes were placed on a nutator for 1 h. Beads were washed 4X with lysis buffer and boiled in 100 µl of sample buffer. Samples were subjected to SDS-PAGE, transferred to the nitrocelluse membrane and immunoblotted with polyclonal antibodies to Kin1, Kin2, Sec9 and Sro7 followed by I 125 -protein A secondary.
DSP Cross-linking
Strains containing high copy SEC9 and high copy KIN1 were grown overnight in SD (S medium with 2% glucose). 6 OD units of cells were labeled with [
35 S]-methionine and cysteine in 4 ml for 1 h at 30°C. Cross-linking and immunoprecipitation were performed as described previously (Lehman et al., 1999) . Labeled cells were washed in PBS-azide, spheroplasted in 1 ml of spheroplast buffer and lysed in 300 µl of PBS with PIC. The lysate was divided into two pools, one treated with the chemical cross-linker dithiosuccinnimidylpropionate (DSP) dissolved in DMSO and the control pool treated with DMSO only. The cross-linker was quenched by ammonium acetate, samples were boiled in 5X boiling buffer (5% SDS, 50 mM Tris pH 8.0, 25 mM EDTA) and diluted 20X with IP buffer (10 mM Tris pH 8, 150 mM NaCl, 0.5% Tween-20, 0.1 mM EDTA). Cell lysates were then subjected to two rounds of IPs. First, samples from both pools were incubated with affinity-purified antibodies to α-Kin1, α-Sec9 and preimmune IgG overnight at 4°C. Immune complexes were pooled via protein A-Sepharose. For the second round of IPs beads were resuspended in the reducing boiling buffer (1% SDS, 10 mM Tris pH 8.0, 5 mM EDTA, 0.1 mM DTT), boiled, diluted with IP buffer and supernatants subjected to IPs with either affinity purified α-Kin1 or affinity purified α-Sec9 antibodies. Samples were boiled and resolved on 7% SDS-PAGE and a 35 S signal was detected by autoradiography.
Non-Native Immunoprecipitation and Phosphatase Treatment
Yeast strains containing high copy SEC9 and either inducible KIN2 on GAL/LEU/CEN integrative vector or GAL/LEU/CEN empty vector were grown in SC medium with 3% raffinose overnight and induced with 1% galactose for 4 hours at 25ºC. 100 OD units/each were harvested, washed, spheroplasted in eppendorf tubes (5 OD/tube) and lysed in 40 µl/tube TEAE/Sorbitol (10 mM TEA, 1 mM EDTA, pH 7.2, 0.8 M sorbitol with 1X protease inhibitor mix). Lysates were centrifuged, combined with an equal volume of 2X boiling buffer (10 mM Tris pH 8.0, 25 mM EDTA pH 8.0, 1% SDS), boiled at 95ºC for 5 min and diluted 20X with IP buffer (10 mM Tris pH 8.0, 150 mM NaCl, 0.1 mM EDTA, 0.5% Tween-20). Combined supernatants were distributed into eppendorf tubes (1.4 ml/tube) and immunoprecipitated with antisera to Sec9 (6µl/tube) overnight on ice. Immune complexes were pooled down with protein A-Sepharose (65µl/tube) for 2 h at 4ºC and washed with IP buffer 5 times. Combined beads were distributed into eppendorf tubes (25 µl bed volume/tube), which were subjected to 5 different treatments: 1) boiled immediately; 2) incubated 1:1 with 2X restriction buffer 3 and 2 µl/tube of calf intestinal phosphatase (CIP) for 30 min at 37ºC; 3) incubated with 2X buffer 3 only for 30 min at 37ºC (mock control for CIP); 4) incubated 1:1 with 2X λ-phosphatase buffer and λ-phosphatase (1.5 µl/tube) for 30 min at 30ºC; 5) incubated with 2X λ-phosphatase buffer only for 30 min at 30ºC (mock control for λ-phosphatase). Samples were boiled, separated on an 8% gel and immunoblotted with α-Sec9 antibody.
Purification of the recombinant proteins
All GST-fusion proteins were produced, purified and their protein concentrations estimated as described (Rossi et al., 1997) .
In vitro kinase assays
Yeast strains containing high copy KIN1, KIN2 or empty vector were grown on SC-D (SC medium with 2% glucose) overnight and switched to YP-D medium for 2.5 hours. Cells were harvested (33 OD units/1 IP reaction), washed in 10:20:20 buffer, spheroplasted, lysed and subjected to native immunoprecipitation with antibodies to Kin1, Kin2 or preimmune serum as described above. Immune complexes were pulled down with Protein A-Sepharose (60 µl of 1:1 slurry /1 IP), beads were washed twice with lysis buffer and twice with PK buffer (50 mM Tris pH 7.5, 5 mM MgCl 2 ), combined and distributed into eppendorf tubes. For one kinase reaction (total volume of 50 µl) we used 25 µl of 1:1 bead slurry, 1.5 µM recombinant protein, 1XPKi buffer (50 mM Tris pH 7.5, 5 mM MgCl 2 , 1 mM DTT), 0.1 mM cold ATP and 1 µl 32 P-ATP. The kinase reaction was incubated at 30ºC for 30 min, spun and supernatant containing recombinant proteins was boiled in an equal volume of sample buffer. Samples were subjected to 15% SDS-PAGE, gels were dryed and exposed to film.
In vivo kinase assays
Cells containing multicopy SEC9 and GAL-KIN2 (GAL-KIN2/CEN/LEU2) or empty vector control (GAL/CEN/LEU2) were grown O/N in S medium with 3% raffinose to an OD599 of 0.5. Next day the cells were split in half and shifted into fresh medium containing either S with 2% raffinose or YP-low phosphate with 2% raffinose for 1 h at 27ºC. 2 ODs of the culture grown in S with 2% raffinose were then induced with 1% galactose and labelled with 35 S-methionine (0.28 µCi/ml) for 4 h at 27ºC. 2 ODs of the culture growing in YP-low phosphate with 2% raffinose were simultaneously induced with 1% galactose in the presence of 32 P-orthophosphate (10 µCi/µl) for 4 h at 27ºC. At the end of the incubation the cultures were spun in glass tubes for 5 min at 25ºC. All samples were washed in Tris (10 mM), sodium azide (20 mM) and sodium fluoride (20 mM) and then spheroplasted in spheroplast buffer (100 mM Tris, 1.2 M sorbitol, 10 mM sodium azide, 0.015% betamercaptoethanol and 0.1 mg/ml of zymolyse 100T) for 30 min at 37ºC. Subsequently, samples were spun in eppendorf tubes for 5 min at 2000 rpm. The pellets were lysed in 75 µl of ice-cold 1XPBS and then boiled immediately in 2X boiling buffer (2% SDS, 20 mM Tris pH 8 and 10 mM EDTA) for 5 min at 95ºC. Samples were diluted with 1 ml of IP buffer (10 mM Tris pH 8, 150 mM NaCl, 0.5% Tween-20 and 0.1 mM EDTA) and microfuged for 10 min at 4ºC. Supernatants were then removed, further diluted in IP buffer and used for immunoprecipitations with respective antibodies for 1 h on ice. For 32 P-orthophosphate labeled cells, RNAse A (DNAase, Protease free, Sigma) was added to 30 µg/ml (1 µl enzyme/ml of IP buffer) to reduce background on gels from radio-labeled RNA contaminants. Immune complexes were pulled down with Protein A Sepharose, washed with IP buffer and IP buffer with 2 M Urea and 1% betamercaptoethanol before boiling in 100 µl of SB. Samples were run on SDS polyacrylamide gels, dried and exposed to film.
RESULTS

KIN1 and KIN2 are potent suppressors of secretion defective alleles of Rho3 and Cdc42
Rho3 is a member of the Rho family of GTPases that exhibits multiple genetic and physical interactions with components of the exocytic machinery and is itself required for efficient exocytosis Robinson et al., 1999) . To isolate candidate downstream effectors of RHO3 function in exocytosis we performed a genetic screen for dosage suppressors of the slow growth phenotype of a RHO3 deletion strain (rho3∆). We constructed a strain containing the RHO3 coding sequence under the control of the glucose repressible GAL promoter as the only source of Rho3 in the cell. This strain, which grows normally on galactose-containing media but extremely slowly in glucosecontaining media, was transformed with a yeast genomic library prepared in a multi-copy vector, and transformants were selected for growth on glucose-containing medium. Plasmids from colonies growing on glucose were isolated, retested for suppression and then analyzed by sequencing. From this analysis we identified 25 suppressing plasmids containing overlapping parts of 6 distinct loci. Five of the six loci had genes previously isolated as dosage suppressors of a rho3∆ mutant: BEM1 (1 isolate), SRO9 (1 isolate), SEC4 (2 isolates), SSO2 (3 isolates) and RHO3 itself (17 isolates) (Imai et al., 1996; Adamo et al., 1999) . Subcloning of the various regions in the sixth locus identified the suppressing gene to be coincident with the KIN1 gene ( Figure 1A ). While several suppressors of rho3∆ (SEC4, SRO7, SRO77, SEC9, SSO2) are known components of the late secretory machinery, the function of KIN1 is not known. The KIN1 open reading frame alone was sufficient to suppress rho3∆ and thus, we identified KIN1 as a novel dosage suppressor of Rho3.
Mutations in RHO3 affect both actin organization and post-Golgi vesicle transport (Imai et al., 1996; Adamo et al., 1999) . The rho3-V51 cold-sensitive mutant has a secretory defect in the absence of functional and structural perturbations of the actin cytoskeleton, hence, this mutant affects a function of Rho3 in exocytosis that is independent of actin . To determine whether Kin1 functions specifically in the secretory pathway downstream of Rho3, we assessed the ability of KIN1 to suppress the rho3-V51 mutant. rho3-V51 is viable at 25ºC, but not at 14ºC. Figure 1B shows that overexpression of KIN1 resulted in restoration of growth of the rho3-V51 mutant at the restrictive temperature (14ºC). In addition, we have previously reported that the growth defect of cdc42-6, the secretion-impaired mutant of another Rho GTPase, is specifically suppressed by introduction of KIN1 on the multi-copy plasmid (Adamo et al., 2001) . This suppression was specific to cdc42-6, since KIN1 failed to suppress more pleiotropically defective alleles of CDC42 such as cdc42-1.
Since the coding sequence of KIN2 is quite similar to that of KIN1 (51% identity) we asked if they shared a common function downstream of Rho3 and Cdc42 by determining the ability of high-copy KIN2 to suppress the growth defects associated with rho3-V51 and cdc42-6 mutant strains. As shown in Table I , we found that KIN2 strongly suppressed the growth defect of these mutants at their respective restrictive temperatures (14ºC for rho3V-51 and 32ºC for cdc42-6) and the potency of KIN2 was identical to that of KIN1. The fact that both kinases specifically suppress secretory defective alleles of Rho3 and Cdc42 suggests that both KIN1 and KIN2 act in the secretory pathway downstream of the Rho GTPases.
KIN1 and KIN2 exhibit genetic interactions with components of the late secretory machinery
The ability of KIN1 and KIN2 to suppress the cdc42-6 and rho3-V51 alleles suggests a possible role for these kinases in the regulation of exocytosis. To further explore this idea we examined the ability of multicopy KIN1 and KIN2 to suppress the temperaturesensitive growth defect of a number of secretory (sec) mutants. An example of the suppression analysis, summarized in Table II , is shown in Figure 2 . Elevated dosage of KIN1 and KIN2 restored the growth of the late sec mutants sec4-P48 and sec15-1to wildtype levels at 14ºC and 35ºC, respectively ( Figure 2 ). sec4-P48 is a cold-sensitive effector domain mutant of the Rab GTPase SEC4 (Brennwald et al., 1994) , while sec15-1 is a temperature-sensitive mutant of one of the components of the Exocyst complex, Sec15 (TerBush and Novick, 1995) . We examined the secretory defect in sec15-1 cells with multicopy KIN2 compared to control sec15-1 cells containing empty vector following a shift to the restrictive temperature. This analysis demonstrated that while unsuppressed sec15-1 cells are found to accumulate 36% of Bgl2 internally, the accumulation is reduced to wild-type levels in sec15-1 cells containing high-copy KIN2 where only 18% of Bgl2 is found internally. Therefore the suppression of the growth defect was found to correlate closely to suppression of the secretion defect in these cells.
Suppression analysis demonstrated that KIN1 and KIN2 also suppress the growth defect of a number of other late secretory mutants. These include the temperature-sensitive mutants of two additional components of the Exocyst complex; Sec3 (sec3-2) and Sec10 (sec10-2), which were rescued at the non-permissive temperature of 35ºC by introduction of KIN1 and KIN2 on high copy. Also, we show that expression of multi-copy KIN1 and KIN2 restores the growth of sec1-1 at 33ºC and sec2-41 at 33ºC. sec1-1 is a mutant of SEC1 which is involved in SNARE assembly (Carr et al., 1999) , and sec2-41 is a mutant in SEC2, the nucleotide exchange factor for Sec4 (Walch-Solimena et al., 1997) . Thus, KIN1 and KIN2 exhibit strong genetic interactions with multiple components of the exocytic machinery. The suppression profile of KIN1 was identical to that of KIN2, providing additional evidence in favor of the functional redundancy of the two kinases (Table IV) . The ability of KIN1 and KIN2 to suppress several late sec mutant genes indicates that they function downstream of these proteins at the later stage of exocytosis.
However, we found that KIN1 and KIN2 do not suppress the temperature sensitive phenotype of the sec9-4 mutant (Table II) , a mutant of the t-SNARE Sec9 which is defective in SNARE complex assembly and which is required for vesicle fusion with the plasma membrane (Rossi et al., 1997) , nor do they suppress the growth defect of sro7/77∆, a mutant with a double disruption of genes encoding Sec9 binding proteins Sro7 and Sro77 (Table IV) . These observations place Kin1 and Kin2 function downstream of polarized vesicle delivery and upstream of the terminal fusion event.
Analysis of the structural requirements for KIN1 and KIN2 function in the secretory pathway
To elucidate the nature of Kin1 and Kin2 function in the secretory pathway we determined the minimal domain requirement that confers suppression. Kin1 and Kin2 contain a kinase domain at the N-terminus of the protein and a regulatory domain at the C-terminus ( Figure 3A ). The kinase domain as well as the 42 amino acid stretch on the extreme carboxyl terminus are highly conserved between Kin1 and Kin2 and a number of their orthologs from other species. As Kin1 and Kin2 proteins display structural and functional redundancy, we focused on Kin2. Mutant KIN2 constructs with deletions of the kinase domain or the 42 amino acid C-terminal tail were designed to assess the significance of these domains for Kin2 function in the secretory pathway. The following mutants were generated: KIN2-NT, lacking the regulatory C-terminal domain of the protein; kin2-CT, lacking the catalytic N-terminal domain; kin2-KD, the kinase-dead mutant, where a single critical Lys 128 residue in the second catalytic domain (conserved residue mapped by kinase sequences alignment (Hanks et al., 1988) ) was mutated to a Met and finally the KIN2-∆42 mutant, with a deletion of the conserved 42 amino acid Cterminal tail ( Figure 3A) .
Function was assayed by analysis of the suppression properties of the KIN2 mutants expressed at high copy. The suppression of the mutant phenotype of several late sec genes was tested, including sec15-1 and sec4-P48, sec1-1, sec2-41 and sec10-2 (Fig.  3B ). Wild type KIN2 on a multi-copy plasmid behaved as reported above (Figure 2 and  Table II) , restoring the viability of these mutants at certain restrictive temperatures. The kinase-inactive KIN2 mutants: kin2-CT, lacking the entire kinase domain and kin2-KD, the kinase-dead mutant, failed to suppress the growth defect of all sec mutants tested ( Figure 3B ). This data demonstrates that the catalytic activity of Kin2 is critical for its function in the secretory pathway.
Multi-copy expression of KIN2-NT, lacking the entire C-terminal domain, and KIN2-∆42, lacking the 42 amino acid C-terminal tail, rescued the growth phenotype of all late sec mutants tested: sec15-1, sec4-P48, sec1-1, sec2-41 and sec10-2 ( Figure 3B) . Thus, the regulatory domain of Kin2 is functionally dispensable. Furthermore, we observed that the KIN2-NT and KIN2-∆42 mutants at high copy gain the ability to suppress several secretory mutants: sec1-1, sec2-41 and sec10-2, at temperatures at which the wild-type KIN2 failed to suppress ( Figure 3B ). The sec1-1 and sec2-41 temperaturesensitive mutants are suppressed at 33ºC and the sec10-2 mutant at 35ºC in a comparable fashion by KIN2, KIN2-NT and KIN2-∆42 (data not shown). However, KIN2 fails to suppress sec1-1 at 35ºC and sec2-41 and sec10-2 at 37ºC, whereas the KIN2-NT mutant with the deletion of the regulatory domain is able to rescue these mutants at the more restrictive temperatures. Remarkably, the truncation of the distal 42 amino acids at the Cterminus of KIN2, in KIN2-∆42, is sufficient to phenocopy the gain of function observed by KIN2-NT. Both mutant forms of KIN2 are capable of suppressing sec1-1 at 35ºC and sec2-41 and sec10-2 at 37ºC ( Figure 3B ). These data demonstrate that the C-terminal non-kinase domain of Kin2 acts as a negative regulator of Kin2 function in the secretory pathway, and that the conserved 42 amino acid tail is essential for this negative regulatory function.
The greater potency of the Kin2 constructs lacking the distal C-terminal sequence might reflect the acquisition of the catalytically "active" protein conformation in the absence of the putatively inhibitory C-terminal tail. Possibly, in a dormant state the wild type kinase exists in a closed conformation, with the tail bound to the catalytic core, hindering it's activity, until the "ON" regulatory event relieves this auto-inhibition ( Figure 3C ). This hypothesis presupposes the presence of a direct physical interaction between the tail of Kin2 and its kinase domain. To test whether this intramolecular interaction takes place we employed a yeast two-hybrid analysis. We created the following constructs: Kin2-CT and Kin2-CT∆42 (encoding the regulatory domain with and without the C-terminal tail region, respectively) as GAL4 binding domain fusions and Kin2 (full-length protein), Kin2-NT (kinase domain), Kin2-CT (regulatory domain), Kin2-CT∆42 (regulatory domain with the deletion of the C-terminal 42 amino acids) and Kin2-∆42 (full-length protein with the deletion of C-terminal 42 amino acids) as GAL4 activation domain fusions. All constructs in activation and binding domain fusions were expressed at comparable levels as verified by Western blot analysis (data not shown). We found that the C-terminal regulatory domain of Kin2 (Kin2-CT in GAL4BD) binds to the catalytic N-terminal domain of Kin2 (Kin2-NT in GAL4AD) (Table III) . Moreover, this interaction is mediated by the conserved 42 amino acid tail, as it is abolished by truncation of the tail region in the C-terminal domain of Kin2: Kin2-CT∆42 does not bind to Kin2-NT. Kin2-CT does not interact with itself, which is consistent with the regulatory domain interacting with the kinase domain only. In addition, while Kin2-CT fails to interact with the full-length Kin2, it shows interaction with the C-terminally truncated Kin2, Kin2-∆42 (lacking the distal 42 amino acids). This result may signify that Kin2-CT associates with Kin2 in a presumably "open" or active conformation, as in Kin2-∆42, but not with Kin2 in a closed conformation, as in full-length kinase. Thus, yeast two-hybrid analysis revealed that the regulatory domain of Kin2 binds to its catalytic domain and that the 42 amino acid tail is a prerequisite for this interaction. To further support the possible interaction of the Kin1/2 kinase domain with the C-terminal domain we examined of the ability of the domains to interact in vitro. We made use of a recombinant GST-fusion of the kinase domain and in vitro translated C-terminal domain fragments containing either the intact C-terminus, Kin2-CT (523-1147) or an identical domain lacking the conserved C-terminal 42 amino acids, Kin2-CT∆42 (523-1106) . The results shown in Figure 3C demonstrate that these domains do, in fact, interact and that this interaction requires the C-teminal 42 residues of the Kin2. Taken together the in vitro binding data and the 2-hybrid analysis strongly suggest that the C-terminal regulatory domain of Kin2 physically interacts with the N-terminal kinase domain to mediate an autoinhibitory regulation of the kinase. Furthermore, we show that the highly conserved 42 amino acid tail of Kin2 is critical for the both the physical interaction between these domains and for the negative regulatory effect of the C-terminal domain as demonstrated by the effects on suppression of the late sec mutants. Taken together this strongly suggests that C-terminal domain of Kin1/2 functions as an autoinhibitory domain and that this autoinhibition requires the highly conserved C-terminal 42 amino acids. This provides the first mechanistic insight into to the function of this highly conserved 42 residue sequence at the C-terminus of all Par-1 family kinases.
The kinase domain of SNF1, but not other kinases of the CaMK group show suppression properties of the Kin1 and Kin2 kinases
It was previously reported that deletion of either KIN1 or KIN2 is neither lethal, nor deleterious for cell growth (Lamb et al., 1991; Donovan et al., 1994) . Since our data demonstrated functional redundancy of KIN1 and KIN2, we proceeded to analyze whether the presence of at least one of these genes is required for cell viability. We created strains carrying single or double disruptions of these genes by homologous recombination. Consistent with the previous reports, kin1∆ and kin2∆ single disruptant strains were viable. The double disruptant kin1∆, kin2∆ progeny obtained by crossing of the kin1∆ strain with kin2∆, demonstrate normal growth at all temperatures tested (25ºC, 14ºC, 37ºC). The single, kin1∆ and kin2∆, and double kin1∆, kin2∆ disruptants did not exhibit any significant defects in growth or secretion, as confirmed by invertase secretion assays (data not shown).
KIN1 and KIN2 orthologues in S. pombe, C. elegans, D. melanogaster and mammalian cells display pronounced gene disruption phenotypes. Hence, it is likely that in S. cerevisiae other molecule/s act to substitute the compromised function of Kin1 and Kin2. Kin1 and Kin2 belong to the CaMK protein kinase group, members of which share significant sequence similarity in the catalytic domain. Therefore, we examined whether other kinases of this group display functional redundancy with Kin1 and Kin2. BLAST search was used to identify the closest homologues of Kin1 and Kin2, and, as a result, we considered seven proteins of the CaMK group for further analysis, including: Snf1, Hsl1, Gin4, Kcc4, Ypl141c, Kin4 and Ypl150w. To determine whether these proteins act in the secretory pathway we tested their ability to rescue the growth defect of sec2-41, sec10-2 and sec15-1. Since several members of the CaMK group, such as Hsl1, Gin4 and Kcc4 bear a sequence at the distal carboxyl tail almost identical to that of Kin1 and Kin2, we hypothesized that they might be subjected to a similar mode of auto-regulation as Kin2. To overcome this possible auto-inhibition we generated deletion constructs of SNF1 (encoding amino acids 1-432), HSL1 (1-462), GIN4 (1-432), KCC4 (1-437), YPL141C (1-387), KIN4 (1-366) and YPL150W (1-426), which lack the regulatory domain, while preserving intact all regions important for catalytic activity based on sequence alignment. These constructs were introduced on a multi-copy plasmid into sec15-1, sec10-2 and sec2-2 mutants and incubated at permissive and non-permissive temperatures. We show that the catalytic domain of SNF1 (SNF1-NT) suppresses the growth defect of sec15-1, sec10-2 and sec2-2 mutants (Figure 4) . Furthermore, the suppression of sec mutants by SNF1-NT is comparable to that of KIN2-NT. By contrast, constructs encoding the catalytic domains of Hsl1, Gin4, Kcc4, Ypl141C, Kin4 and Ypl150W failed to restore growth of the sec mutants at restrictive temperatures to any significant degree. Our data demonstrate that Snf1, which is structurally closer to Kin1 and Kin2 than any of the other seven members of the CaMK group, is the only kinase, out of those tested, that may function redundantly with Kin1 and Kin2 in exocytosis.
To test whether the function of at least one of these genes, KIN1, KIN2 or SNF1, is essential for cell viability we generated the strain with a triple disruption, kin1∆, kin2∆, snf1∆. kin1∆, kin2∆, snf1∆ was created by substitution of SNF1 with the Kan R (Kanamycin) gene sequence in the context of the diploid strain homozygous for the KIN1 deletion (kin1∆) and heterozygous for the KIN2 deletion (kin2∆). A triple disruptant was obtained via sporulation and tetrad analysis. The triple mutant kin1∆, kin2∆, snf1∆ as well as the double kin1∆, snf1∆, and kin2∆, snf1∆ mutants displayed slow growth phenotype inherent to the SNF1 deletion alone (Celenza and Carlson, 1984) . The kin1∆, kin2∆, snf1∆ triple mutant did not display any synthetic defect in growth or secretion (as verified by invertase secretion assays, data not shown).
Kin1 and Kin2 physically associate with components of the late exocytic machinery
As genetic data place Kin1 and Kin2 function to the late secretory pathway, we analyzed whether these proteins physically associate with any of the components of the exocytic machinery.
Initially, we generated antibodies to detect Kin1 and Kin2 and characterized their localization in budding yeast. Antibodies were raised against a region in the C-terminal domain of Kin1 and Kin2. Affinity-purified antisera were tested by Western blot analyses on samples containing either high copy KIN1 and KIN2 or empty vector ( Figure  5A ). Kin1 and Kin2 antisera specifically recognized each protein and did not cross-react with the other gene product, with both proteins running on SDS-PAGE at around 145 kDa as predicted by the estimated molecular weight (Lamb et al., 1991; Donovan et al., 1994) . Next, we analyzed the intracellular distribution of Kin1 and Kin2 by cell fractionation. Lysates from cells overexpressing Kin1 or Kin2 were treated with or without Triton X-100 and centrifuged at 30,000xg. Supernatant and pellet fractions obtained were analyzed by SDS-PAGE and Western blot with anti-Kin1, anti-Kin2 and anti-Sso1/2 (as an internal control) antibodies ( Figure 5B ). We determined that ~70% of both Kin1 and Kin2 appear in the supernatant or cytosolic fraction (precisely, 71.5% of Kin1 and 73.7% of Kin2 as an average of 3 or more experiments) and the remaining ~30% is found in the pellet or membrane-bound fraction. Therefore, consistent with the previous report (Tibbetts et al., 1994) , Kin1 and Kin2 partition to both cytosolic and membrane-associated pools in S. cerevisiae.
Genetic data suggest that Kin1 and Kin2 act downstream of Rho3, Cdc42, Sec4 and components of the Exocyst complex, but upstream of the t-SNARE Sec9 and the Sec9-binding protein Sro7. Therefore, we hypothesized that Kin1 and Kin2 interact and function together with proteins important for the final stages of exocytosis, such as the SNAREs. To test this we employed the candidate approach to search for Kin1 and Kin2 interacting partners. First, we observed that antibodies against both Kin1 and Kin2 bring down the t-SNARE Sec9 when both genes are expressed at high copy ( Figure 6A ). Sec9 immunoprecipitation with Kin1 and Kin2 antibodies was detected with the endogenous levels of Kin1 and Kin2 as well (data not shown). To confirm that Kin1 exists in a protein complex with Sec9 by a different method we used a chemical cross-linking procedure. Cells from strains overexpressing both KIN1 and SEC9 were labeled with [
35 S]-methionine for 1 hour and then lysed. Lysed cells were treated with the chemical crosslinker (DSP) and subjected to two rounds of immunoprecipitation. In the first round, samples were divided into two pools and incubated with affinity-purified antibodies either against Kin1 or against Sec9, immune complexes formed were pulled down via protein A-Sepharose. In the second round, each of the two pools was subjected to a denaturing immunoprecipitation with either anti-Sec9 or anti-Kin1 antibodies. Our results show that in the presence of the crosslinker Kin1 co-immunoprecipitates Sec9 and, in its turn, Sec9 pulls down Kin1 ( Figure 6B ).
To identify other potential Kin1 and Kin2 interacting partners we performed a series of native immunoprecipitation experiments testing for the association of Kin1 and Kin2 with proteins acting in the secretory pathway. Namely, we examined whether antibodies against Kin2 can pull down two other exocytic SNAREs, Sso and Snc, the Sec9-interacting protein Sro7 and the Rab GTPase Sec4. Kin2 was immunoprecipitated from the cell lysates carrying multi-copy KIN2 and the sample was analyzed by Western blotting with α-Kin2, α-Sso2, α-Snc1, α-Sro7 and α-Sec4 antibodies, respectively. This experiment revealed that the α-Kin2 antibody brings down significant amounts of Sro7, a homologue of a tumor suppressor protein Lgl (lethal giant larvae), but not other proteins tested (Fig. 6C) . As expected, Sro7 also co-immunoprecipitates with anti-Kin1 antibodies (data not shown). Therefore, Kin1 and Kin2 associate with t-SNARE Sec9 and the Sec9-binding protein, Sro7.
To determine whether association of Kin1 and Kin2 with Sec9 and Sro7 is a result of a direct binding between these proteins we employed a yeast two-hybrid analysis. Kin1 and Kin2 in both GAL4-binding and GAL4-activation domain fusions did not show interaction with neither Sec9 nor Sro7 in GAL4-activation and GAL4-binding fusions, respectively (data not shown). This indicates that the interaction of Kin1 and Kin2 with Sec9 and Sro7 is not direct, but occurs via other intermediaries in the complex.
The physical association of Kin1 and Kin2 with the SNARE machinery supports the hypothesis that these Par-1 counterparts play a role in exocytosis at a stage between vesicle docking site recognition and fusion with the plasma membrane.
Kin1 and Kin2 induce phosphorylation of Sec9 in vivo and its release from the plasma membrane to the cytosol Next, we focused on finding a downstream target of Kin1 and Kin2 function in the exocytic pathway. We observed that the interaction partner of Kin1 and Kin2, the t-SNARE Sec9, undergoes a size shift upon transient overexpression of the catalytically active Kin2 kinase ( Figure 7A ). Overexpression of Kin1 gave a similar shift in Sec9 mobility but induction of the kinase-dead mutants of Kin1 and Kin2 failed to induce any detectable shift in Sec9 (data not shown). To test whether this shift is indeed the result of phosphorylation we analyzed the effect of phosphatase treatment on the mobility of immunoprecipitated Sec9 protein following Kin2 induction. Cells carrying either vector alone or CEN/GAL KIN2 were incubated in galactose-containing medium for 4 hours to induce Kin2 expression and lysates obtained from these cells were subjected to immunoprecipitation with anti-Sec9 antibodies. Sec9-containing immune complexes were subsequently treated with two different phosphatases: λ-phosphatase or calf intestinal phosphatase (CIP). Phosphatase treatment, but not mock control treatment, completely abolished the Kin2-dependent size shift of Sec9, demonstrating that the change in Sec9 mobility in response to Kin2 induction is indeed due to phosphorylation ( Figure 7A ).
We next examined whether Sec9 is phosphorylated directly by Kin1/Kin2 in vitro. We made use of recombinant Sec9 protein as a substrate in an in vitro kinase reaction and looked for γ 32 P-ATP incorporation in the presence of immunoprecipitated Kin1/Kin2 proteins bound to Protein A sepharose beads. The data shown represents phosphorylation reactions in the presence of Kin2, however, we found virtually identical results for immunoprecipitated Kin1 in these assays. The recombinant Sec9 protein was initially divided into three domains, Sec9-NT1 (amino acids 1-168), Sec9-NT2 (amino acids 166-401) and Sec9-CT (corresponding to the SNAP25 domain amino acids 401-651), each of which were fused to GST, expressed in bacteria and purified as described previously (Rossi et al., 1997) . This analysis demonstrated that the Sec9-NT2 protein turned out to be an excellent substrate for Kin2 ( Figure 7B , panel 1), with phospho-acceptor activity significantly greater than that of casein, which was previously identified as a test substrate of Kin1 and Kin2 in vitro (Lamb et al., 1991; Donovan et al., 1994) . We subsequently mapped the site of Sec9 phosphorylation by Kin2 to Serine 315 by sequential deletion and mutagenesis of serine or threonine residues to alanine. In particular we found that the substitution of serine 315 to alanine completely abolished the ability of Kin2 to phosphorylate Sec9-NT2 in vitro ( Figure 7B, panel 2) . We used the same strategy to map a significantly weaker in vitro phosphoacceptor site in the SNAP-25 domain of Sec9 to Serine 632 (data not shown). We next determined the effect of the mutation of these sites on the Kin2 induced phosphorylation of Sec9 in vivo. Surprisingly we found that the Sec9-S315A as well as Sec9-S315A, S632A proteins were identical to wild-type Sec9 in the Kin2 induced phosphorylation as judged by a mobility shift ( Figure 7C ). Therefore, the major phosphoacceptor sites on Sec9 phosphorylated by Kin2 in vitro are not responsible for Kin2 induced phosphorylation of Sec9 in vivo. This result indicates that in vivo Kin1/Kin2 are unlikely to directly phosphorylate Sec9, but rather this phosphorylation occurs as a downstream effect of Kin1/Kin2 inductionpresumably by direct or indirect activation of a kinase, which in turn phosphorylates Sec9 at a site or sites other than Serine 315.
To assess the specificity of the catalytic activity of Kin1 and Kin2 we examined whether other components of the late exocytic machinery are phosphorylated by these kinases. In vivo experiments were performed on cells carrying either vector alone or CEN/GAL KIN2, radioactively labeled with 32 P-orthophosphate during a 4 hour induction of Kin2 in galactose-containing medium. Lysates from these cells were immunoprecipitated with antibodies against Sec9, Sso1/2, Sro7 and a number of components of the Exocyst complex and a subset of small GTPases involved in secretion. An identical set of strains was simultaneously labeled with [ 35 S]-methionine to control for the presence of the proteins in the lysates examined. Proteins were separated on SDS-PAGE and their phosphorylation state was determined by autoradiography. Out of all proteins tested only Sec9 displayed an increased level of 32 P-orthophosphate incorporation in cells overexpressing Kin2 (Figure 8) . Thus, Kin2 specifically induce the phosphorylation of Sec9. These data allows us to hypothesize that Kin1 and Kin2 act in the secretory pathway by regulating the phosphorylation of the t-SNARE, Sec9.
To address the functional significance of the Sec9 phosphorylation induced by Kin1 and Kin2 we tested whether expression of these kinases affects the subcellular localization of Sec9. We analyzed the distribution of Sec9 into pellet and supernatant fractions after centrifugation at 30,000xg in galactose-induced and uninduced cells carrying CEN/GAL KIN1. In uninduced cells (as well as in cells carrying empty CEN/GAL vector, data not shown) ~50 to 60% of Sec9 is cytosolic and partitions into the supernatant fraction, whereas the rest is membrane-bound (the Triton-sensitive pellet fraction) (Figure 9 ). Interestingly, in cells expressing CEN/GAL KIN1 the proportion of the cytosolic Sec9 is increased relative to the membrane-bound Sec9 (Figure 9 ). Averaging three independent experiments, induction of Kin1 expression resulted in reproducible elevation of the cytosolic Sec9 levels to ~70-75% of the total Sec9 pool. As expected, Kin1 does not alter distribution of Sso1/2 under identical conditions (Figure 9 ). Furthermore, Sec9 undergoes a Kin1-mediated mobility shift exclusively in the cytosolic, but not membrane fraction. As expected, induction of KIN2 had the same effect on Sec9 distribution (data not shown). Thus, overexpression of Kin1 or Kin2 results in release of a fraction of Sec9 from the plasma membrane into the cytosol.
To determine the effect of GAL-induced Kin1 overexpression on overall growth and secretory function we examined the ability of sec1-1 cells transformed with a GAL-KIN1 construct to grow and secrete the periplasmic protein Bgl2. As shown in figure 9B , we find that galactose-induced expression of Kin1 protein results in dramatic suppression of the growth defect at the non-permissive temperature of 33 o C. Suppression by GAL-KIN1 is lost when the cells are grown on non-inducing YPD media. We examined the ability of galactose induced sec1-1 transformants to secrete Bgl2 following a shift to restrictive temperature. As shown in Figure 9C , we find that control sec1-1 cells containing an empty GAL vector show an accumulation of internal Bgl2. In contrast cells containing GAL-KIN1 show a dramatic suppression of the secretory defect to levels of internal Bgl2 found in wild-type yeast cells. Therefore the same conditions of Kin1 overexpression which result in a reduction of Sec9 levels on the membrane, also yield an overall "gain of function" in the secretory pathway.
Based on these data we suggest that the positive effect of Kin1 and Kin2 on the secretory pathway may be mediated through regulation of the plasma membrane t-SNARE Sec9. Consistent with this assumption, overexpression of SEC9 suppresses growth defects of a number of late sec mutants that are also suppressed by introduction of multi-copy KIN1 and KIN2. High copy SEC9 is known to restore the viability of rho3∆, sec4-P48, sec1-1, sec3-2, sec8-9, sec9-4, sec15-1 (Lehman et al., 1999) . When we compared the relative suppression capabilities of high copy KIN1, KIN2 and SEC9, we found that KIN1 and KIN2 largely mimic the SEC9 suppression profile and exert an effect either equal or less potent in comparison to that of SEC9 (Table IV) . The only mutant that KIN1 and KIN2, but not SEC9, are capable of suppressing is sec2-41, the significance of which remains to be addressed. Taken together our results are consistent with Kin1 and Kin2 acting in the secretory pathway by positively regulating Sec9 function.
DISCUSSION
Novel role for Par-1: regulation of exocytosis Par-1 is a key regulator of polarity axis formation in a number of organisms. This includes the anterior-posterior axis of the C. elegans zygote and the Drosophila oocyte and the apico-basal axis of polarized epithelia in Drosophila and mammalian cells. Par-1 has been proposed to regulate cell fate determination and polarized cell morphology by positioning polarity markers, modulating activity of signaling pathways such as Wnt (canonical) and PCP (planar cell polarity) and re-organizing the microtubule cytoskeleton (Kemphues et al., 1988; Drewes et al., 1997; Tenenhaus et al., 1998; Shulman et al., 2000; Cox et al., 2001; Huynh et al., 2001; Sun et al., 2001; Vaccari and Ephrussi, 2002; Benton and Johnston, 2003; Doerflinger et al., 2003; Cohen et al., 2004) . This is the first report linking Par-1 to regulation of exocytosis. Here, we show that the yeast Par-1 counterparts, Kin1 and Kin2, exhibit multiple genetic and physical interactions with components of the exocytic machinery and thus function in the postGolgi secretory pathway in S. cerevisiae. We demonstrate that both KIN1 and KIN2 suppress the growth abnormality of rho3∆, rho3-V51, sec1, sec2, sec3, sec4, sec10 and sec15, mutants of genes important for polarized vesicle transport and docking. However, we observed that neither KIN1 nor KIN2 suppress sec9-4 and sro7∆, sro77∆, which are mutants of proteins involved in SNARE complex assembly and fusion. Thus, our genetic data position Kin1 and Kin2 function between the vesicle docking and fusion stages of exocytosis, and identify these kinases as downstream effectors of the small GTPases: Rho3, Cdc42, Sec4 and several components of the vesicle tethering machinery. Moreover, these structurally homologous proteins display functional redundancy as well, since they show an identical pattern of suppression of the late secretory mutants. Consistent with genetic evidence, the analysis of physical associations of Kin1 and Kin2 show that these proteins exist in a complex with proteins necessary for fusion of exocytic vesicles with the plasma membrane. We demonstrate that Kin1 and Kin2 coimmunoprecipitate with the t-SNARE Sec9, and the homologue of the Drosophila tumor suppressor lethal giant larvae, Sro7, which has been previously reported to bind to Sec9 (Lehman et al., 1999) . Based on physical and genetic data we propose that Kin1 and Kin2 transmit a signal from the upstream-acting GTPases and the docking complex to the SNARE proteins to ensure correct vesicle fusion.
How conserved is the role of Par-1 in exocytosis? A high degree of functional conservation was observed for proteins constituting the Golgi-to-cell surface vesicle delivery machinery including the Exocyst complex and the SNARE proteins (Kee et al., 1997; Rossi et al., 1997) . Therefore, potentially, a link between Par-1 and the polarized exocytic machinery might represent a universal feature. Remarkably, a collaboration with Dr. Anne Muesch at Cornell Medical College revealed that mammalian Par-1 (EMK1) exists in a protein complex with the basolateral t-SNARE Syntaxin 4 and the Exocyst components in MDCK cells (unpublished data, personal communication), suggesting that Par-1 is involved in the regulation of exocytosis in polarized mammalian cells as well. Nevertheless, there are some differences between the two systems. In MDCK cells EMK1 interacts with the t-SNARE Syntaxin 4, but not with the mammalian equivalent of Sec9, SNAP25. On the other hand, our group did not detect any association between Kin1/Kin2 and Sso1/2, the yeast counterparts of the mammalian syntaxins. Thus, although Par-1 function in exocytosis is likely to be conserved, the precise molecular mechanism of signal transduction by Par-1 might differ from species to species.
Mechanism of Kin1 and Kin2 function
Analysis of a kinase-dead mutant of Kin1 and Kin2 in yeast showed that the catalytic activity of these kinases is essential for suppression of sec mutants and, thus, for function in exocytosis. Therefore, we focused on finding a target and downstream effector of Kin1 and Kin2 in the secretory pathway. We assessed the ability of these kinases to phosphorylate a number of components of the late exocytic machinery including the postGolgi SNAREs. We found that the t-SNARE Sec9 is the only protein out of those tested that is phosphorylated in vivo upon overexpression of Kin1 and Kin2. While we cannot exclude the possibility that another, as yet untested, component of the exocytic machinery is the target of Kin1/2 function in this pathway, the genetic and biochemical evidence provided here strongly suggest that Sec9 is the ultimate target of Kin1/2 action on exocytosis. Despite the fact that Sec9 can serve as a direct substrate of Kin1 and Kin2 in vitro, analysis of a phospho-mutant of Sec9 revealed that in vivo Kin1/Kin2-mediated phosphorylation of Sec9 is likely to be indirect. It is unclear, at the present time which protein kinase transmits the signal from Kin1/Kin2 to Sec9.
How is the t-SNARE Sec9 regulated by yeast Par-1 orthologs? Recent studies demonstrated that SNARE protein stability, localization, assembly into functional complexes is amenable to regulation by phosphorylation and dephosphorylation as is the final process of membrane fusion itself (Foster LJ, 1998; Cabaniols JP, 1999; Peters C, 1999; Risinger C, 1999; Chung SH, 2000; Kataoka M, 2000; Lin and Scheller, 2000; Verona M, 2000; Marash M, 2001; Pombo et al., 2001; Nagy et al., 2002; Polgar et al., 2003; Tian et al., 2003; Nagy et al., 2004) . Here, we show that Kin1 and Kin2 alter the intracellular distribution of Sec9. At steady-state Sec9 is distributed approximately equally between the cytosol and the membrane. We observed that expression of Kin1 and Kin2 results in depletion of the membrane pool of Sec9 and induces phosphorylation of cytosolic Sec9. Thus, yeast Par-1 orthologs either release membrane-bound Sec9 or prevent its attachment to the membrane by yet unknown mechanism involving phosphorylation of the t-SNARE. Our data suggest that Kin1 and Kin2 transmit a signal to the secretory pathway by increasing the level and, possibly, activity of Sec9 in the cytosol. Consistent with this, overexpression of KIN1 and KIN2 produced the same effect as overexpression of SEC9 with respect to restoration of the growth of a number of sec mutants. The only mutant that we found to be rescued by KIN1 and KIN2, but not by SEC9 overexpression, is sec2, encoding an exchange factor for Sec4. It can be either due to Kin1/Kin2 having an additional function independent of regulation of Sec9 or, alternatively, Sec9 might require Kin1/Kin2-induced phosphorylation to gain suppression of sec2.
The increase in the proportion of Sec9 in the cytosol induced by Kin1 and Kin2 suggests a mechanism by which their action promotes exocytosis. Previous work has suggested that Sec9 represents the limiting component in the formation of plasma membrane SNARE complexes and is present in wild-type cells in molar amounts that are 5-10 fold lower than the other two SNAREs it forms complexes with: Sso1/2 and Snc1/2 (Brennwald et al., 1994) . Therefore increasing amounts of Sec9 available for formation of SNARE complexes either by increasing overall Sec9 protein levels (i.e. increasing SEC9 dosage) or increasing the proportion of free Sec9 available to form SNARE complexes would be expected to have strong positive effect on exocytic activity. However, it is known that SNARE complex assembly occurs on the plasma membrane. The question, addressed in the following three paragraphs, is: how does Kin1/2-mediated release of Sec9 from the membrane into the cytosol promotes exocytosis?
It is likely that Kin1 and Kin2 phosphorylate and release from the membrane free, unassembled Sec9 for two reasons. First, we have not detected the interaction between Kin1/Kin2 and two other exocytic SNAREs: the t-SNARE Sso and the v-SNARE Snc. Second, we have not detected a dramatic difference in the amount of Sec9 present in SNARE complexes as a consequence of Kin1 or Kin2 activity (unpublished observation) and, thus, this pathway does not affect steady-state amounts of SNARE complexes present. Nevertheless, it cannot be completely ruled out that Kin1 and Kin2 phosphorylate a fraction of Sec9 in "old", inactive SNARE complexes and initiate its release, priming Sec9 for a new round of vesicle fusion.
Importantly, while it may seem contradictory that elevation of unassembled SNARE levels in the cytosol at the expense of the membrane-bound pool promotes vesicle fusion, we hypothesize that Sec9 is recruited from the cytosolic rather than the membrane pool into new SNARE complexes. Under this assumption, the more efficient release of Sec9 from the membrane induced by Kin1 and Kin2 phosphorylation replenishes the pool of assembly-competent Sec9 near sites of recruitment. Consequently, increased cycling of Sec9 would promote complex assembly and vesicle fusion. Thus, we think that Kin1 and Kin2 promote secretion by increasing the pool of Sec9 available for incorporation into new, active SNARE complexes.
It is also possible that Kin1 and Kin2 help to spatially direct SNARE complex formation by locally priming Sec9 for assembly. In S. cerevisiae fusion of vesicles is restricted to the tip of the bud. Nevertheless, the t-SNARE Sec9 is not polarized, in fact, it localizes ubiquitously in the cytoplasm and homogenously over the entire perimeter of the plasma membrane (Brennwald et al., 1994) . Distribution of the other t-SNARE, Sso, is also non-polar (Brennwald et al., 1994) . Therefore, other molecules are required to restrict formation of fusion-competent SNARE complexes to the bud tip. Exogenous Kin1 and Kin2 localize ubiquitously in the cell (our unpublished observation). However, based on our genetic data these kinases act downstream of molecules directing polarized vesicle transport and docking, such as Rho3, Cdc42, Sec4 and the Exocyst complex. Thus, Kin1 and Kin2 are likely to be activated and regulate Sec9 in a polarized fashion, possibly by phosphorylating and releasing Sec9 from the membrane locally, near the sites of fusion.
Structural insights: the conserved 42 amino acid tail function in auto-inhibition
The C-terminal 42 amino acid tail sequence (termed "KA1" domain) is highly conserved throughout Par-1 orthologs from yeast to mammalian cells. Nevertheless, the role of this conserved segment remained unknown. Our data show that deletion of these 42 amino acids results in the gain of function of the kinase in the secretory pathway. Kin2 constructs with a deletion of the tail display stronger suppression of the growth defect of sec mutants relative to the wild-type kinase, suggesting that the tail plays an inhibitory role. Binding of the regulatory domain of the kinase to its catalytic core is a known mechanism of kinase auto-inhibition (Hu et al., 1994; Tu et al., 1997; Tu and Wigler, 1999; Tan et al., 2001) . Inhibition can happen via two scenarios: in cis, with one molecule circling on itself (as shown in Fig. 3D) , and in trans, mediated through head-totail dimer formation. In a "closed" configuration an inhibitory segment inactivates a kinase by blocking either the ATP-or the substrate-binding sites. Consistent with this mechanism of auto-inhibition, we show that catalytic (N-terminal) and regulatory (Cterminal) domains of Kin2 directly interact with each other and that this interaction requires an intact 42 amino acid tail sequence. Hence, we provide functional and physical evidence for the inhibitory role of the C-terminal tail. Considering a remarkable degree of conservation of the tail sequence between Par-1 orthologs, it is likely that the autoinhibitory function of the tail is conserved as well.
Conclusions
In summary, we report three novel findings. First, we demonstrate that yeast Par-1 counterparts are associated with and appear to positively regulate the function of the exocytic apparatus. Second, we show that Kin1 and Kin2 induce phosphorylation of Sec9 and its release from the plasma membrane to the cytosol, promoting its recycling and/or availability for incorporation into newly formed SNARE complexes. Third, we find that the conserved 42 amino acid tail of the yeast Par-1 orthologs plays a role in autoinhibition.
This suggests an interesting possibility that the role of Par-1 in cell polarity establishment in a variety of organisms might be tied to the control of Golgi-to-plasma membrane vesicle targeting. It is possible to envision that the primary function of Par-1 is to regulate polarized secretion, which in turn is necessary for proper localization of polarity determinants and microtubule capture/stabilization, processes that require Par-1 in a number of species. It remains to be seen how essential and conserved is the function of Par-1 in exocytosis.
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FIGURE LEGENDS
Figure 2. KIN1 and KIN2 suppress late secretory mutants. KIN1 and KIN2 suppress the cold-sensitivity of the sec4-P48 mutant (A) and the temperature-sensitivity of the sec15-1 mutant (B). Mutants were transformed with KIN1 and KIN2 on high copy plasmids, cultured on selective media at 25°C, replica plated from the microtiter plates to YPD media and incubated at restrictive (14°C for sec4-P48 and 35°C for sec15-1) and permissive (25°C) temperatures. Figure 3 . Analysis of the structural requirements for suppression of the secretory mutants by KIN2. A. A schematic representation of the structure of Kin2 (conserved regions are indicated in red) and Kin2 mutants. Five constructs were examined. KIN2: wild-type; KIN2-NT: a mutant lacking the C-terminal domain; kin2-CT: a mutant lacking the kinase domain; kin2-KD a kinase-dead mutant with a lysine to methionine substitution at residue 128 (the asterisk indicates the position of the point mutation); KIN2-∆42: a mutant with a deletion of the conserved 42 amino acid C-terminal tail. B. Suppression assays show that the catalytic activity of Kin2 is essential for it's function, and that the conserved 42 amino acid tail plays a role in auto-inhibition. Constructs described above along with the high copy vector control were transformed into sec4-P48, sec15-1, sec1-1, sec2-41 and sec10-2 mutant strains, plated on YP-D media and cultured at permissive (25°C) and their respective restrictive temperatures. kin2-KD and kin2-CT failed to suppress the growth defect of all sec mutants tested. KIN2-∆42 and KIN2-NT exhibited suppression of sec1-1 at 35°C and sec2-41 and sec10-2 at 37°C, whereas KIN2 suppresses these mutants at 33°C only. C. In vitro binding of Kin2 C-terminus to the N-terminal Kin2 kinase domain demonstrates an intramolecular interaction which depends on the 42 amino acid tail. Kin2-CT or Kin2-CT∆42 proteins (as shown in A) were in vitro translated in reticulocyte lysates and bound to GST fusion proteins immobilized on glutathione agarose beads. (A) Affinity-purified antibodies against the C-terminal domains of Kin1 and Kin2 recognize proteins in a specific manner, running at ~145kDa on SDS-PAGE. Wild type cells and cells containing either KIN1 or KIN2 on high copy were subjected to 7% SDS-PAGE and Western Blot using affinity-purified antibodies against Kin1 and Kin2. (B) Kin1 and Kin2 are found in both the cytosolic and membrane-bound pools. Lysates from cells containing either vector alone, KIN1 or KIN2 on high copy were treated with or without Triton X-100 and centrifuged at 30,000xg for 15 min. Supernatant and pellet fractions were analyzed (T-total, S30-supernatant, P30-pellet) by SDS-PAGE (pellet fractions were resuspended in the volume equal to that of S30 fraction) and blotted with anti-Kin1 and anti-Kin2 antibodies. ~70% of both Kin1 and Kin2 appear in the cytosolic fraction and ~30% is in a Triton-sensitive membrane fraction. Samples were also immunoblotted with anti-Sso1/2 polyclonal antibody as an internal control of the fractionation procedure (consistent with previous reports ~80% of Sso1/2 was detected in the pellet fraction). Cell lysates carrying either high copy KIN1 and SEC9 or high copy KIN2 and SEC9 were subjected to native immunoprecipitation with preimmune serum (PI) and either anti-Kin1 or anti-Kin2 antibodies (I), respectively, as described in MATERIALS AND METHODS. Samples were separated on 8% SDS-PAGE and immunoblotted with antiSec9 and either anti-Kin1 or anti-Kin2 antibodies, respectively. "T" stands for total protein in the lysate before IP, loaded at 1:20 to the amount of lysate used to immunoprecipitate Kin1 and Kin2 in (PI) and (I) lanes. (B) Crosslinking experiment confirms association between Kin1 and Sec9. Cells expressing SEC9 and KIN1 on a multi-copy plasmid were [
35 S]-labeled for 1 h and lysed osmotically in PBS. Lysates were subjected to cross-linking, followed by two rounds of immunoprecipitations, initially with α-Kin1 and α-Sec9 antibodies, followed by a denaturing IP with α-Kin1 and α-Sec9 antibodies. Samples were run on 7% SDS-PAGE and the 35 S labelled protein was detected by autoradiography. (C) Kin2 co-associates with Sro7, but not with Snc1, Sso2 or Sec4. Lysates from cells transformed with high copy KIN2 were subjected to native immunoprecipitation with preimmune serum (PI) and α-Kin2 antibody (I) as described in MATERIALS AND METHODS, followed by SDS-PAGE and immunoblot with α-Kin2, α-Sro7, α-Snc1, α-Sso2 and α-Sec4 antibodies. Immune complexes were treated with λ-phosphatase and calf intestinal phosphatase (CIP) for 30 min at 30ºC and 37ºC, respectively. Untreated and mock-treated samples, incubated under identical conditions, were used as a control. Samples were subjected to 8% SDS-PAGE and immunoblotted with α-Sec9 antibody. (B) N-terminus of Sec9 is a substrate of Kin2 in vitro. Cells expressing Kin2 were subjected to immunoprecipitation with either α-Kin2 antibody (I) or preimmune serum (PI) as a negative control. Immobilized Kin2 on protein A-Sepharose beads was used for in vitro kinase assays. Equal molar amounts (1.5 µM) of soluble recombinant Sec9-NT1 (amino acids 1-168), Sec9-NT2 (amino acids 166-401) and Sec9-CT (amino acids 402-651) were added to the reaction and incubated with 32 P-ATP for 30 min at 30ºC. Samples were analyzed by SDS-PAGE and autoradiography (panel 1). In panel 2, wild-type Sec9-NT2 and Sec9-NT2-S315A mutant were tested in an in vitro kinase reaction as described above. Concentrations of recombinant proteins used in the kinase reaction were measured by a Bradford protein assay, normalized to equal concentrations and verified by Coomassie staining. (C) Sec9 is not a direct target of Kin2 in vivo. Lysates from cells containing CEN/GAL vector or CEN/GAL Kin2 containing multi-copy wild-type Sec9 or mutant Sec9-S315A were induced with galactose for 4 hours. Cells were then spheroplasted and lysed and the lysates boiled and separated by SDS-PAGE and immunoblotted with antiSec9. Arrows indicate Sec9 mobility shift. Figure 8 . Sec9 is the only component of the exocytic apparatus tested that is phosphorylated upon Kin2 induction. Cells containing empty vector, or GAL-KIN2 were induced with galactose for 2 hours prior to labelling with either 35 S-methionine or 32 Porthophosphate. Denatured cell lysates were prepared and immunoprecipitated with antibodies to the components of the late secretory machinery. Phosphate-incorporation was detected by SDS-PAGE and autoradiography. Quantitation demonstrated that the when cells were induced with GAL-KIN2 the amount of 32 P label incorporated into Sec9 increased 3 fold. The small increase in 32 P labeling in the cells lacking GAL-KIN2 was due to slight increase in overall 32 P labeling in this sample. Lysates from galactose-induced and uninduced cells containing CEN/GAL KIN1 and high copy SEC9 were treated with or without Triton X-100 and centrifuged at 30,000xg for 15 min. Supernatant and pellet fractions were subjected to SDS-PAGE and blotted with antiSec9 antibodies (T: total, S30: 30k xg supernatant, P30: 30k x g pellet). The proportion of Sec9 in the cytosolic and Triton-sensitive membrane fraction was quantified as an average of three independent experiments. Samples were also immunoblotted with antiSso1/2 polyclonal antibody as an internal control. B. Suppression of the sec1-1 growth defect by GAL-KIN1. sec1-1 mutants were transformed with empty vector or GAL-KIN1 and replicated for growth at permissive (25 o C) and restrictive (33 o C) temperatures on media which induces (YP-Gal) or represses (YPD) overexpression of the Kin1 protein. C. Suppression of the sec1-1 secretion defect by GAL-KIN1. sec1-1 mutant strains containing empty vector or GAL-KIN2 were induced for two hours in galactose, shifted to 33 o C for 2 hours and then processed for Bgl2 secretion (defects in secretion are seen as an increase in the fraction of Bgl2 found internally). ------rho3-V51 and cdc42-6 mutants were transformed with either vector (pRS426), KIN1 or KIN2 on high copy, cultured on selective medium at RT and replica plated from the microtiter plates to YP-D media. Growth of transformants at mutant's restrictive temperatures, 14°C for rho3-V51 and 32°C for cdc42-6, was tested. Scoring reflects the colony growth at restrictive temperatures relative to the wild-type yeast (++++) and to the empty vector control (---). 
